Biote (BTMD) Liabilities and Shareholders Equity (2020 - 2026)

Biote's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $89.0 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 27.84% year-over-year to $89.0 million; the TTM figure through Mar 2026 stood at $412.8 million (down 6.17% YoY), while the FY2025 annual figure was $107.6 million, down 12.06% from the prior year.
• Liabilities and Shareholders Equity was $89.0 million for Q1 2026 at Biote, down from $107.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $317.9 million in Q1 2022 to a low of $89.0 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $131.2 million across 5 years, with a median of $115.3 million in 2022.
• Biggest YoY gain for Liabilities and Shareholders Equity was 105.49% in 2022; the steepest drop was 65.57% in 2022.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $111.6 million in 2022, then soared by 39.1% to $155.3 million in 2023, then decreased by 21.2% to $122.4 million in 2024, then slipped by 12.06% to $107.6 million in 2025, then retreated by 17.27% to $89.0 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $89.0 million (Q1 2026), $107.6 million (Q4 2025), and $111.3 million (Q3 2025), per Business Quant data.